Phase 2 ER Positive Breast Cancer Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Breast CancerER Positive Breast CancerHER2-positive Breast Cancer+1 more
Ruth O'Regan30 enrolled4 locationsNCT04886531
Recruiting
Phase 2
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
HER2-negative Breast CancerER Positive Breast Cancer
The Methodist Hospital Research Institute28 enrolled1 locationNCT05305924
Recruiting
Phase 2
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Breast CancerBreast Cancer FemaleHER2-Negative Breast Carcinoma+4 more
Sarah Sammons, MD58 enrolled3 locationsNCT06176261
Recruiting
Phase 2
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Metastatic Breast CancerER Positive Breast CancerPremenopausal Breast Cancer
National Taiwan University Hospital42 enrolled1 locationNCT05720260